Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Re-inventing a better wheel? Serplulimab for squamous cell lung cancer.

Derek De-Rui Huang,James Chih-Hsin Yang

Cancer cell（2024）

Cited 0|Views10
No score
Abstract
Immune checkpoint inhibitors have reshaped the treatment landscape of non-small cell lung cancer (NSCLC). However, chemoimmunotherapy trials dedicated to squamous NSCLC are limited. In this issue of Cancer Cell, Zhou et al. demonstrate serplulimab plus chemotherapy as an effective first-line regimen to treat patients with advanced squamous NSCLC.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined